Pharmala Biotech HoldingsMDMA 
$0.174.17%24h
4.17%24h
Global rank28920
Market cap$14.66M
Change 7d8.70%
YTD Performance-
SP500 benchmark
P/E-17.34
P/S39.72
Revenue$369.01K
Earnings-$540.90K
Dividend yield-
Main Sector
Healthcare
Category
EPS for Pharmala Biotech Holdings (MDMA)
Pharmala Biotech Holdings has an EPS of $-0.01. In 2022, the company made an earnings per share (EPS) of $-0.01. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for MDMA
-
Value:-
EPS history for Pharmala Biotech Holdings from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.01 | 0.00% |
| 2022 | -$0.01 | -66.92% |
| 2021 | -$0.03023 | - |
View the highest EPS stocks
